[A case of hepatoma treated successfully with a percutaneous intratumoral injection of CDDP-PC-lipiodol suspension].
Reported is a case that was treated successfully with a percutaneous intratumoral injection of a CDDP-PC-Lipiodol Suspension (CPLS) of the viable tumor cells of a hepatoma after arterial injection therapy. Although the size of the viable tumor cells remained almost unchanged, a marked reduction in the level of the plasma AFP (484 ng/ml-35 ng/ml) was obtained after the percutaneous injection. No major complication was encountered except for minimal vomiting and mild transient abnormalities of the liver functions.
Aikawa
H
H
Dept. of Radiology, Medical College of Oita.
Maeda
H
H
Nakashima
A
A
Ashizawa
A
A
Mori
H
H
Azimu
A
A
Hirao
K
K
Isomoto
I
I
Matuoka
Y
Y
Monzen
Y
Y
D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage*; D004361:Drug Tolerance; D006801:Humans; D007267:Injections / Q000379:methods; D007459:Iodized Oil / Q000008:administration & dosage*; D008113:Liver Neoplasms / Q000097:blood / Q000188:drug therapy*; D008297:Male; D010713:Phosphatidylcholines / Q000008:administration & dosage*; D013501:Surface-Active Agents / Q000008:administration & dosage; D013535:Suspensions; D000509:alpha-Fetoproteins / Q000378:metabolism
D010713:Phosphatidylcholines; D013501:Surface-Active Agents; D013535:Suspensions; D000509:alpha-Fetoproteins; D007459:Iodized Oil; D002945:Cisplatin